-
1
-
-
0037418066
-
Current concepts in the diagnosis and management of Parkinson's disease
-
Guttman M, Kish SJ, Furukawa Y. Current concepts in the diagnosis and management of Parkinson's disease. CMAJ 2003;168(3):293-301.
-
(2003)
CMAJ
, vol.168
, Issue.3
, pp. 293-301
-
-
Guttman, M.1
Kish, S.J.2
Furukawa, Y.3
-
2
-
-
0032837272
-
Range of neuropsychiatric disturbances in patients with Parkinson's disease
-
Aarsland D, Larsen JP, Lim NG, et al. Range of neuropsychiatric disturbances in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1999;67:492-6.
-
(1999)
J Neurol Neurosurg Psychiatry
, vol.67
, pp. 492-496
-
-
Aarsland, D.1
Larsen, J.P.2
Lim, N.G.3
-
3
-
-
33646107153
-
Practice Parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
-
Miyasaki JM, Shannon K, Voon V, et al. Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. J Neurology 2006;66:996-1002.
-
(2006)
J Neurology
, vol.66
, pp. 996-1002
-
-
Miyasaki, J.M.1
Shannon, K.2
Voon, V.3
-
5
-
-
0023753297
-
Evidence for atypical depression in Parkinson's disease
-
Schiffer RB, Kurlan R, Rubin A, et al. Evidence for atypical depression in Parkinson's disease. Am J Psychiatry 1988;145:1020-2.
-
(1988)
Am J Psychiatry
, vol.145
, pp. 1020-1022
-
-
Schiffer, R.B.1
Kurlan, R.2
Rubin, A.3
-
6
-
-
33645151619
-
Depression in neurological disorders: Parkinson's disease, multiple sclerosis, and stroke
-
Rickards H. Depression in neurological disorders: Parkinson's disease, multiple sclerosis, and stroke. J Neurol Neurosurg Psychiatry 2005;70(Suppl 1):148-52.
-
(2005)
J Neurol Neurosurg Psychiatry
, vol.70
, Issue.SUPPL. 1
, pp. 148-152
-
-
Rickards, H.1
-
7
-
-
0033693186
-
The validity of the Beck Depression Inventory as a screening and diagnostic instrument for depression in patients with Parkinson's disease
-
Leentjens AF, Verhey FR, Liujckx GJ, et al. The validity of the Beck Depression Inventory as a screening and diagnostic instrument for depression in patients with Parkinson's disease. Mov Disord 2000;15:1221-4.
-
(2000)
Mov Disord
, vol.15
, pp. 1221-1224
-
-
Leentjens, A.F.1
Verhey, F.R.2
Liujckx, G.J.3
-
8
-
-
0033853816
-
The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease
-
Leentjens AF, Verhey FR, Lousberg R, et al. The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease. Int J Geriatr Pdychiatry 2000;15:644-9.
-
(2000)
Int J Geriatr Pdychiatry
, vol.15
, pp. 644-649
-
-
Leentjens, A.F.1
Verhey, F.R.2
Lousberg, R.3
-
9
-
-
17744384689
-
Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease
-
Mossner R, Henneberg A, Schmitt A, et al. Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease. Mol Psychiatry 2001;6:350-2.
-
(2001)
Mol Psychiatry
, vol.6
, pp. 350-352
-
-
Mossner, R.1
Henneberg, A.2
Schmitt, A.3
-
10
-
-
0028822713
-
Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease: A double-blind, placebo-controlled study
-
Maricle RA, Nutt JG, Valentine RJ, et al. Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease: a double-blind, placebo-controlled study. Neurology 1995;45:1757-60.
-
(1995)
Neurology
, vol.45
, pp. 1757-1760
-
-
Maricle, R.A.1
Nutt, J.G.2
Valentine, R.J.3
-
11
-
-
22144452936
-
The feasibility of using cognitive behaviour therapy for depression associated with Parkinson's disease: A literature review
-
Cole K, Vaughan FL. The feasibility of using cognitive behaviour therapy for depression associated with Parkinson's disease: a literature review. Parkinsonism Relat Disord 2005;11:260-76.
-
(2005)
Parkinsonism Relat Disord
, vol.11
, pp. 260-276
-
-
Cole, K.1
Vaughan, F.L.2
-
12
-
-
27744564717
-
Antidepressant studies in Parkinson's disease: A review and meta-analysis
-
Weintraub D, Morales KH, Moberg PJ, et al. Antidepressant studies in Parkinson's disease: a review and meta-analysis. Mov Disord 2005;20:1161-9.
-
(2005)
Mov Disord
, vol.20
, pp. 1161-1169
-
-
Weintraub, D.1
Morales, K.H.2
Moberg, P.J.3
-
13
-
-
0032949690
-
Do serotonin reuptake inhibitor antidepressants worsen Parkinson's disease? A retrospective case series
-
Richard IH, Maughn A, Kurlan R. Do serotonin reuptake inhibitor antidepressants worsen Parkinson's disease? A retrospective case series. Mov Disord 1999;14:155-7.
-
(1999)
Mov Disord
, vol.14
, pp. 155-157
-
-
Richard, I.H.1
Maughn, A.2
Kurlan, R.3
-
14
-
-
0032942169
-
Management of Parkinson's disease: A review of current and new therapies
-
Mendis T, Suchowersky O, Lang A, et al. Management of Parkinson's disease: a review of current and new therapies. Can J Neurol Sci 1999;26:89-103.
-
(1999)
Can J Neurol Sci
, vol.26
, pp. 89-103
-
-
Mendis, T.1
Suchowersky, O.2
Lang, A.3
-
15
-
-
0030987172
-
Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease
-
Parkinson Study Group
-
Richard IH, Kurlan R, Tanner C, et al. Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease. Parkinson Study Group. Neurology 1997;48:1070-7.
-
(1997)
Neurology
, vol.48
, pp. 1070-1077
-
-
Richard, I.H.1
Kurlan, R.2
Tanner, C.3
-
17
-
-
28144444507
-
Non-invasive brain stimulation for Parkinson's disease: A systematic review and meta-analysis of the literature
-
Fregni F, Simon DK, Wu A, et al. Non-invasive brain stimulation for Parkinson's disease: a systematic review and meta-analysis of the literature. J Neurol Neurosurg Psychiatry 2005;76:1614-23.
-
(2005)
J Neurol Neurosurg Psychiatry
, vol.76
, pp. 1614-1623
-
-
Fregni, F.1
Simon, D.K.2
Wu, A.3
-
21
-
-
0038084268
-
Prospective study of phobic anxiety and risk of Parkinson's disease
-
Weisskopf MG, Chen H, Schwarzschild MA, et al. Prospective study of phobic anxiety and risk of Parkinson's disease. Mov Disord 2003;18:646-51.
-
(2003)
Mov Disord
, vol.18
, pp. 646-651
-
-
Weisskopf, M.G.1
Chen, H.2
Schwarzschild, M.A.3
-
22
-
-
0022893596
-
Buspirone, Parkinson's disease, and the locus ceruleus
-
Ludwig CL, Weinberger DR, Bruno G, et al. Buspirone, Parkinson's disease, and the locus ceruleus. Clin Neuropharmacol 1986;9:373-8.
-
(1986)
Clin Neuropharmacol
, vol.9
, pp. 373-378
-
-
Ludwig, C.L.1
Weinberger, D.R.2
Bruno, G.3
-
23
-
-
11244349103
-
The ups and downs of Parkinson disease: A prospective study of mood and anxiety fluctuations
-
Richard IH, Franks, McDermott MP, et al. The ups and downs of Parkinson disease: a prospective study of mood and anxiety fluctuations. Cogn Behav Neurol 2004;17:201-7.
-
(2004)
Cogn Behav Neurol
, vol.17
, pp. 201-207
-
-
Richard, I.H.1
Franks2
McDermott, M.P.3
-
24
-
-
22144475386
-
Psychotic symptoms in Parkinson's disease. From description to etiology
-
Papapetropoulos S, Mash DC. Psychotic symptoms in Parkinson's disease. From description to etiology. J Neurol 2005;252:753-64.
-
(2005)
J Neurol
, vol.252
, pp. 753-764
-
-
Papapetropoulos, S.1
Mash, D.C.2
-
25
-
-
0342424352
-
Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors
-
Fenelon G, Mahieux F, Huon R, et al. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain 2000;123:733-45.
-
(2000)
Brain
, vol.123
, pp. 733-745
-
-
Fenelon, G.1
Mahieux, F.2
Huon, R.3
-
26
-
-
0034983839
-
Prospective study of hallucinations and delusions in Parkinson's disease
-
Holroyd S, Currie L, Wooten GF. Prospective study of hallucinations and delusions in Parkinson's disease. J Neurol Neurosurg Psychiatry 2001;70:734-8.
-
(2001)
J Neurol Neurosurg Psychiatry
, vol.70
, pp. 734-738
-
-
Holroyd, S.1
Currie, L.2
Wooten, G.F.3
-
28
-
-
0034973443
-
An algorithm (decision tree) for the management of Parkinson's disease (2001): Treatment guidelines
-
Olanow CW, Watts RL, Koller WC. An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines. Neurology 2001;56 (Suppl 5):S1-S88.
-
(2001)
Neurology
, vol.56
, Issue.SUPPL. 5
-
-
Olanow, C.W.1
Watts, R.L.2
Koller, W.C.3
-
29
-
-
19544378167
-
Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias
-
Aarsland D, Perry R, Larsen JP, et al. Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias. J Clin Psychiatry 2005;66:633-7.
-
(2005)
J Clin Psychiatry
, vol.66
, pp. 633-637
-
-
Aarsland, D.1
Perry, R.2
Larsen, J.P.3
-
30
-
-
0038485957
-
Long-term outcome of quetiapine use for psychosis among Parkinsonian patients
-
Fernandez HH, Trieschmann ME, Burke MA, et al. Long-term outcome of quetiapine use for psychosis among Parkinsonian patients. Mov Discord 2003;18:510-4.
-
(2003)
Mov Discord
, vol.18
, pp. 510-514
-
-
Fernandez, H.H.1
Trieschmann, M.E.2
Burke, M.A.3
-
31
-
-
2342443881
-
Quetiapine improves psychotic symptoms and cognition in Parkinson's disease
-
Juncos JL, Roberts VJ, Evatt ML, et al. Quetiapine improves psychotic symptoms and cognition in Parkinson's disease. Mov Disord 2004;19:29-35.
-
(2004)
Mov Disord
, vol.19
, pp. 29-35
-
-
Juncos, J.L.1
Roberts, V.J.2
Evatt, M.L.3
-
32
-
-
0034107042
-
Atypical antipsychotics in the treatment of drug-induced psychosis hi Parkinson's disease
-
Friedman JH, Factor SA. Atypical antipsychotics in the treatment of drug-induced psychosis hi Parkinson's disease. Mov Disord 2000;15:201-11.
-
(2000)
Mov Disord
, vol.15
, pp. 201-211
-
-
Friedman, J.H.1
Factor, S.A.2
-
33
-
-
26444527544
-
Treatment of dementia with Lewy bodies and Parkinson's disease dementia
-
Poewe W. Treatment of dementia with Lewy bodies and Parkinson's disease dementia. Mov Disord 2005;26(Suppl 12):S77-82.
-
(2005)
Mov Disord
, vol.26
, Issue.SUPPL. 12
-
-
Poewe, W.1
-
34
-
-
1542374145
-
Progress in clinical neurosciences: Parkinson's disease with dementia and dementia with Lewy bodies
-
Camicioli R, Fisher N. Progress in clinical neurosciences: Parkinson's disease with dementia and dementia with Lewy bodies. Can J Neurol Sci 2004;31:7-21.
-
(2004)
Can J Neurol Sci
, vol.31
, pp. 7-21
-
-
Camicioli, R.1
Fisher, N.2
-
35
-
-
33846016934
-
Neuropsychiatric symptoms in patients with PD and dementia: Frequency, profile and associated caregiver stress
-
[Epub ahead of print 2006 July 4]. Available: (accessed 2006 Oct 6)
-
Aarsland D, Bronnick K, Ehrt U, et al. Neuropsychiatric symptoms in patients with PD and dementia: Frequency, profile and associated caregiver stress. J Neurol Neurosurg Psychiatry [Epub ahead of print 2006 July 4]. Available: http://jnnp.bmjjournals .com/cgi/rapidpdf/jnnp.2005.083113v1.pdf (accessed 2006 Oct 6).
-
J Neurol Neurosurg Psychiatry
-
-
Aarsland, D.1
Bronnick, K.2
Ehrt, U.3
-
36
-
-
0016823810
-
"Mini-mental state." A practical method for grading the cognitive state of patients for the clinician
-
Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
-
(1975)
J Psychiatr Res
, vol.12
, pp. 189-198
-
-
Folstein, M.F.1
Folstein, S.E.2
McHugh, P.R.3
-
37
-
-
33845678859
-
Guidelines for randomized clinical studies in Parkinson's disease with dementia and dementia with Lewy bodies
-
In press
-
Camicioli R, Gauthier S. Guidelines for randomized clinical studies in Parkinson's disease with dementia and dementia with Lewy bodies. Can J Neurol Sci. In press.
-
Can J Neurol Sci
-
-
Camicioli, R.1
Gauthier, S.2
-
38
-
-
0842325101
-
Randomized placebo-controlled trial ofdonepezil in cognitive impairment in Parkinson's disease
-
Leroi I, Brandt J, Reich SG, et al. Randomized placebo-controlled trial ofdonepezil in cognitive impairment in Parkinson's disease. Int J Geriatr Psychiatry 2004;19:1-8.
-
(2004)
Int J Geriatr Psychiatry
, vol.19
, pp. 1-8
-
-
Leroi, I.1
Brandt, J.2
Reich, S.G.3
-
39
-
-
0031060220
-
Cognitive deficits in Parkinson's disease
-
Dubois B, Pillon B. Cognitive deficits in Parkinson's disease. J Neurol 1997;244:2-8.
-
(1997)
J Neurol
, vol.244
, pp. 2-8
-
-
Dubois, B.1
Pillon, B.2
-
40
-
-
0021328595
-
Parkinson's disease: Neuron loss in the nucleus basalis without concomitant Alzheimer's disease
-
Nakano J, Hirano A. Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease. Ann Neurol 1984;15:415-8.
-
(1984)
Ann Neurol
, vol.15
, pp. 415-418
-
-
Nakano, J.1
Hirano, A.2
-
41
-
-
33144489150
-
Consortium on DLB. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium [published erratum in Neurology 2005;65:1992]
-
McKeith IG, Dickson DW, Lowe J, et al. Consortium on DLB. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium [published erratum in Neurology 2005;65:1992]. Neurology 2005;65:1863-72.
-
(2005)
Neurology
, vol.65
, pp. 1863-1872
-
-
McKeith, I.G.1
Dickson, D.W.2
Lowe, J.3
-
42
-
-
33645328813
-
Progress in clinical neurosciences: Canadian guidelines for the development of antidementia therapies: A conceptual summary
-
Feldman HH, Gauthier S, Chertkow H, et al. Progress in clinical neurosciences: Canadian guidelines for the development of antidementia therapies: a conceptual summary. Can J Neurol Sci 2006;33:6-26.
-
(2006)
Can J Neurol Sci
, vol.33
, pp. 6-26
-
-
Feldman, H.H.1
Gauthier, S.2
Chertkow, H.3
-
43
-
-
33645520639
-
Cholinesterase inhibitors for Parkinson's disease dementia
-
[review]. CD004747
-
Maidment I, Fox C, Boustani M. Cholinesterase inhibitors for Parkinson's disease dementia [review]. Cochrane Database Syst Rev 2006;(1):CD004747.
-
(2006)
Cochrane Database Syst Rev
, Issue.1
-
-
Maidment, I.1
Fox, C.2
Boustani, M.3
-
44
-
-
10044283107
-
Rivastigmine for dementia associated with Parkinson's disease
-
Emre M, Aarsland D, Albanese A, et al. Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med 2004;351:2509-18.
-
(2004)
N Engl J Med
, vol.351
, pp. 2509-2518
-
-
Emre, M.1
Aarsland, D.2
Albanese, A.3
-
45
-
-
0036265213
-
Donepezil for cognitive impairment in Parkinson's disease: A randomised controlled study
-
Aarsland D, Laake K, Larsen JP, et al. Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study. J Neurol Neurosurg Psychiatry 2002;72:708-12.
-
(2002)
J Neurol Neurosurg Psychiatry
, vol.72
, pp. 708-712
-
-
Aarsland, D.1
Laake, K.2
Larsen, J.P.3
-
46
-
-
21344444811
-
Donepezil for dementia in Parkinson's disease: A randomised, double blind, placebo controlled, crossover study
-
Ravina B, Putt M, Siderowf A, et al. Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study. J Neurol Neurosurg Psychiatry 2005;76:934-9.
-
(2005)
J Neurol Neurosurg Psychiatry
, vol.76
, pp. 934-939
-
-
Ravina, B.1
Putt, M.2
Siderowf, A.3
-
47
-
-
0142091310
-
Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia
-
Aarsland D, Hutchinson M, Larsen JP. Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia. Int J Geriatr Psychiatry 2003; 18:937-41.
-
(2003)
Int J Geriatr Psychiatry
, vol.18
, pp. 937-941
-
-
Aarsland, D.1
Hutchinson, M.2
Larsen, J.P.3
-
48
-
-
21044442252
-
Sleep issues in Parkinson's disease
-
Adler CH, Thorpy MJ. Sleep issues in Parkinson's disease. Neurology 2005;64 (Suppl 3):S12-20.
-
(2005)
Neurology
, vol.64
, Issue.SUPPL. 3
-
-
Adler, C.H.1
Thorpy, M.J.2
-
49
-
-
18844365394
-
Excessive daytime sleepiness in parkinsonism
-
Arnulf I. Excessive daytime sleepiness in parkinsonism. Sleep Med Rev 2005;9: 185-200.
-
(2005)
Sleep Med Rev
, vol.9
, pp. 185-200
-
-
Arnulf, I.1
-
50
-
-
33645836498
-
Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder
-
Postuma RB, Lang AE, Massicotte-Marquez J, et al. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology 2006;66:845-51.
-
(2006)
Neurology
, vol.66
, pp. 845-851
-
-
Postuma, R.B.1
Lang, A.E.2
Massicotte-Marquez, J.3
-
51
-
-
0141738376
-
Compulsive use of dopamine replacement therapy in Parkinson's disease Reward systems gone awry?
-
Lawrence AD, Evans AH, Lees AJ. Compulsive use of dopamine replacement therapy in Parkinson's disease Reward systems gone awry? Laacet Neurol 2003;2:595-604.
-
(2003)
Laacet Neurol
, vol.2
, pp. 595-604
-
-
Lawrence, A.D.1
Evans, A.H.2
Lees, A.J.3
-
52
-
-
24944552052
-
Pathological gambling in Parkinson's disease
-
Stocchi F. Pathological gambling in Parkinson's disease. Lancet Neurol 2005;4:590-2.
-
(2005)
Lancet Neurol
, vol.4
, pp. 590-592
-
-
Stocchi, F.1
-
53
-
-
32944480345
-
Impulse control disorders and dopaminergic drugs
-
letter
-
Morgan JC, Iyer SS, Sethi KD. Impulse control disorders and dopaminergic drugs [letter]. Arch Neurol 2006;63:298-9.
-
(2006)
Arch Neurol
, vol.63
, pp. 298-299
-
-
Morgan, J.C.1
Iyer, S.S.2
Sethi, K.D.3
-
55
-
-
23844441981
-
Pathological gambling caused by drugs used to treat Parkinson disease
-
Dodd ML, Klos KJ, Bower JH, et al. Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 2005;62:1377-81.
-
(2005)
Arch Neurol
, vol.62
, pp. 1377-1381
-
-
Dodd, M.L.1
Klos, K.J.2
Bower, J.H.3
-
56
-
-
0014693180
-
L-dopa therapy in Parkinson's disease: A critical review of nine years' experience
-
Barbeau A. L-dopa therapy in Parkinson's disease: a critical review of nine years' experience. CMAJ 1969;101:59-68.
-
(1969)
CMAJ
, vol.101
, pp. 59-68
-
-
Barbeau, A.1
-
57
-
-
0031922957
-
Clozapine for dopaminergic-induced paraphilias in Parkinson's disease
-
Fernandez HH, Durso R. Clozapine for dopaminergic-induced paraphilias in Parkinson's disease. Mov Disord 1998;13:597-8.
-
(1998)
Mov Disord
, vol.13
, pp. 597-598
-
-
Fernandez, H.H.1
Durso, R.2
-
58
-
-
0036338706
-
Reversible transvestic fetishism in a man with Parkinson's disease treated with selegiline
-
Riley DE. Reversible transvestic fetishism in a man with Parkinson's disease treated with selegiline. Clin Neuropharmacol 2002;25:234-7.
-
(2002)
Clin Neuropharmacol
, vol.25
, pp. 234-237
-
-
Riley, D.E.1
-
59
-
-
24944446759
-
Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy
-
Klos KJ, Bower JH, Josephs KA, et al. Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism Relat Discord 2005;11:381-6.
-
(2005)
Parkinsonism Relat Discord
, vol.11
, pp. 381-386
-
-
Klos, K.J.1
Bower, J.H.2
Josephs, K.A.3
-
60
-
-
0025816459
-
Behavioral complications of drug treatment of Parkinson's disease
-
Cummings JL. Behavioral complications of drug treatment of Parkinson's disease. J Am Geriatr Soc 1991;39:708-16.
-
(1991)
J Am Geriatr Soc
, vol.39
, pp. 708-716
-
-
Cummings, J.L.1
|